INVESTOR RELATIONS
-
November 20, 2024 Ironscales -Agreement for the Secondary Sale of holdings of Ironscale
-
November 17, 2024 Resignation of CEO and VP Cyber
-
November 14, 2024 Agreement for the Sale of SixGill
-
October 21, 2024 Update of Dividend Reports
-
October 9, 2024 Elron announces $15 Million Dividend Distribution
-
September 4, 2024 Transaction for which Approval of a General Meeting of Shareholders is not Required
-
September 4, 2024 Changes in the Company’s Board of Directors
-
September 4, 2024 Changes in the holdings of Related Parties
-
September 4, 2024 Completion of Sale of DIC’s Holdings in Elron
-
September 4, 2024 Transaction for which Approval of a General Meeting of Shareholders is not Required
-
September 1, 2024 DIC – update regarding transaction for the sale of DIC’s holdings in Elron
-
August 15, 2024 DIC – Postponement of closing date of the transaction to sell DIC’s holdings in Elron in accordance with the terms of the agreement
-
July 22, 2024 DIC – entering into an agreement for the sale of DIC’s holdings in Elron
-
July 15, 2024 DIC – Response to Media Publication
-
July 9, 2024 DIC –non-binding memorandum of understanding for the sale of its holdings in Elron – an Update
-
July 4, 2024 Translation of Immediate Release – Update Regarding Dividend Distribution
-
June 17, 2024 DIC – Extension of the exclusivity period under the non-binding memorandum of understanding for the sale of its holdings in Elron
-
May 27, 2024 Approach by Potential Purchaser to Board of Directors
-
May 5, 2024 DIC enters into a non-binding Memorandum of Understanding for the sale of its shares in Elron
-
May 5, 2024 Court Approval of Petition to Distribute Dividend
-
April 21, 2024 Translation of Report to the Israel Securities Authority on April 21,2024
-
March 31, 2024 Elron Announces Extension of 2022 Shelf Prospectus Until April 2025
-
March 12, 2024 Translation of Report to the Israel Securities Authority on March 12, 2024
-
February 22, 2024 Elron Files for Court Approval to Distribute Dividend
-
February 20, 2024 Application to the court for a dividend distribution
-
January 22, 2024 Supplemental Immediate Release in connection with Dividend Announcement
-
January 11, 2024 Elron announces NIS96.5 Million Dividend Distribution
-
January 10, 2024 CartiHeal- Completion of Sale Transaction
-
December 28, 2023 Results of 2023 Annual General Meeting
-
November 22, 2023 Sale of CartiHeal
-
May 17, 2023 Appointment of Officers
-
May 17, 2023 Grants to Employee and Officers of Elron Ventures
-
April 2, 2023 CartiHeal – Return of Shares
-
March 9, 2023 Notice of resignation of CFO
-
February 28, 2023 CartiHeal – Settlement Agreement
-
February 14, 2023 CartiHeal- Milestone for the prepayment of the next payment was completed
-
December 28, 2022 Results of 2022 Annual General Meeting
-
November 22, 2022 Bioventus Report for the Third Quarter
-
November 20, 2022 Bioventus’s reports for the third quarter are expected to be published on November 21, 2022
-
November 14, 2022 Elron Announces $34.45 Million Dividend Distribution
-
July 12, 2022 CartiHeal – Closing of Sale Agreement
-
June 20, 2022 CartiHeal – Amendment of Sale Agreement
-
May 10, 2022 Sale of CartiHeal- Update
-
April 12, 2022 Shelf Prospectus
-
April 4, 2022 Bioventus announces exercise of option to acquire Cartiheal
-
March 30, 2022 CartiHeal Received FDA Approval
-
February 10, 2022 Brainsgate – FDA Response
-
January 30, 2022 Elron Ventures Reports on Options Grants
-
January 20, 2022 Elron Ventures Reports on Appointment of an Alternate Director
-
January 19, 2022 Reporting the approval of the Company’s name change to Elron Ventures Ltd
-
December 11, 2021 BrainsGate – External FDA Advisory Panel Vote
-
November 18, 2021 Elron Ventures Reports on Resignation and Appointment of Director & Chairman
-
August 30, 2021 Elron Ventures Announces that Bioventus Decided to Proceed with the Option Agreement with CartiHeal
-
August 26, 2021 Elron Announces FDA Panel to Review BrainsGate’s PMA Application
-
August 3, 2021 CartiHeal – Final Pivotal Clinical Trial Results
-
June 27, 2021 Elron Reports on Appointment of New Director
-
June 18, 2021 Elron Reports On Changes to Its Board of Directors
-
May 23, 2021 Elron Files Immediate Report on Private Offering
-
April 20, 2021 Elron Announces Results of Public Offering
-
April 19, 2021 Elron Reports on Appointment of Zahi Nahmias as Chairman of the Board of Directors
-
April 19, 2021 Elron Files Shelf Offering Report in Israel
-
April 5, 2021 Elron Reports On Changes to Its Board of Directors
-
March 26, 2021 Elron Updates that 47.4% of DIC’s Share Capital Was Transferred to Mega Or and Other Acquirers
-
March 17, 2021 Elron Announces Ministry of Communication’s Approval to Transfer DIC’s Control in Cellcom to Mega Or
-
March 11, 2021 Elron Reports On Expiry of External Director’s Term
-
February 18, 2021 Elron Announces Extension of 2019 Shelf Prospectus Until 2022
-
January 31, 2021 Elron Announces Sale of Alcide to Rapid7
-
December 31, 2020 Elron Announces Resolution to Renew D&O Liability Insurance Policy
-
December 7, 2020 Elron Announces Appointment of Chairman and New Director
-
December 6, 2020 Elron Announces that BrainsGate Completes Financing Round Led by A New Investor
-
November 25, 2020 Elron Announces Appointment of New Directors
-
November 24, 2020 Elron Announces Resignation of Eduardo Elsztain and Saul Zang as Directors
-
November 22, 2020 Elron Reports on Court Decision to Approve the Sale of DIC Shares
-
November 1, 2020 Elron Announces Appointment of Itzik (Isaac) Idan as Director
-
October 29, 2020 Elron Reports On Expiry of External Director’s Term
-
October 26, 2020 Elron Reports On Court Decisions Regarding DIC’s Companies
-
October 11, 2020 CartiHeal’s Agili-C Implant was Granted Breakthrough Device Designation by the FDA
-
September 29, 2020 Elron Reports On Court Decisions Regarding IDB Development
-
September 13, 2020 Elron Updates that IDB Development Published An Independent Appraisal of the Company
-
August 6, 2020 Elron Announces Agreement for the Transfer of Most of Its Holding In Pocared to Naftali Investments owned by Recanati
-
July 20, 2020 Elron CartiHeal-Bioventus Transaction Webinar Translation
-
July 16, 2020 Elron Announces Transaction for an Investment and Option to Sell CartiHeal to Bioventus
-
July 16, 2020 Elron to Host a Webinar to Discuss the CartiHeal-Bioventus Transaction
-
July 16, 2020 Elron CartiHeal-Bioventus Transaction Webinar Presentations
-
July 16, 2020 Elron CartiHeal-Bioventus Transaction Webinar Replay (in Hebrew)
-
May 27, 2020 Elron Files Immediate Report on Private Offering
-
May 6, 2020 Elron Announces that BrainsGate Received CE Approval
-
April 13, 2020 Elron Announces Resignation of Eran Saar as Director
-
March 18, 2020 Elron Announces Appointment of Doron Cohen as Director
-
March 18, 2020 Elron Announces Appointment of Niv Levy as CFO
-
February 26, 2020 Elron Files Immediate Report in Response to Publications in the Israeli Media Regarding CartiHeal
-
February 3, 2020 Elron Announces Appointment of Yaron Elad as CEO
-
February 2, 2020 Elron Announces that BrainsGate Submitted Its PMA Application to the FDA
-
December 30, 2019 Elron Announces that BrainsGate Notified the FDA of Its intention to Submit Its PMA Application During January 2020
-
November 27, 2019 Elron Announces Appointment of Eran Saar as Director
-
November 27, 2019 Elron Announces that CEO Notified Board of Directors of Intention to Resign
-
November 27, 2019 Elron Announces Resolution to Renew D&O Liability Insurance Policy
-
November 24, 2019 CartiHeal – Interim Results
-
October 31, 2019 Elron Announces that CartiHeal Completed Enrollment of Patients for Interim Analysis in FDA Pivotal Trial
-
September 26, 2019 Elron Announces Resignation of Sholem Lapidot as Alternate Director
-
July 1, 2019 Elron Announces that BrainsGate Submitted CE Mark Application for Marketing Approval in Europe
-
June 12, 2019 Elron Updates on Changes in Holdings of Interested Parties
-
June 6, 2019 Elron Announces Results of Public Offering
-
June 5, 2019 Elron Files Shelf Offering Report in Israel
-
June 4, 2019 Elron Announces Results of Tender to Qualified Investors for Early Commitments
-
June 3, 2019 Elron Announces It is Considering a Public Offering and Preparing to Conduct a Tender Offer to Qualified Investors
-
June 3, 2019 Elron Announces Resolution to Increase Scope of D&O Liability Insurance Policy
-
April 30, 2019 Elron Updates on Pocared’s Decision Not to Conduct a Clinical Trial at this Stage
-
April 1, 2019 Elron Announces Resignation of Benjamin Gantz as Director
-
March 18, 2019 Elron Announces Decision to Grant Directors’ Compensation to Controlling Persons
-
February 24, 2019 Elron Announces Filing of Shelf Prospectus in Israel
-
January 10, 2019 Elron Reports Option Grants
-
December 10, 2018 Elron Reports Purchase of Its Shares by Discount Investment Corporation
-
November 27, 2018 Elron Reports Purchases of Its Shares by Discount Investment Corporation
-
November 21, 2018 Elron Announces Update on Pocared’s FDA Trial
-
November 21, 2018 Elron Files Immediate Report on Private Offering
-
October 21, 2018 BrainsGate – Final Results
-
August 22, 2018 Elron Announces Update on the Timing of Pocared’s FDA Trial
-
August 5, 2018 BrainsGate – Preliminary Results
-
June 12, 2018 PFIC Disclosure Statement
-
April 29, 2018 Elron Announces Completion of Secdo Sale to Palo Alto Networks
-
April 10, 2018 Elron Announces Definitive Agreement Signed for Sale of Secdo to Palo Alto Networks
-
March 18, 2018 Elron Announces that Settlement Agreement in the Matter of Elscint Was Given Effect of Judgement
-
March 12, 2018 Elron Announces Last Patient Enrolled in BrainsGate’s FDA Trial
-
February 20, 2018 Elron Announces Update on Timing of Pocared’s FDA Trial
-
January 31, 2018 Elron Announces Resolution Regarding Compensation to Independent Directors
-
November 23, 2017 Elron Announces Change in Ownership of Parent Company
-
November 2, 2017 Elron Announces Court Approval of Complementary Settlement Agreement in the Matter of Elscint
-
September 26, 2017 Elron Announces that CartiHeal Enrolled First Patients in FDA Pivotal Trial
-
September 5, 2017 Elron Announces Update on Timing of BrainsGate’s and Pocared’s FDA Trials
-
August 30, 2017 Elron Files Form 15F to Terminate Its Registration Under the Securities Exchange Act of 1934
-
August 28, 2017 Elron Announces Board of Directors Decision Regarding Voluntary SEC Deregistration and Discontinuation of Reporting Obligations in the U.S.
-
July 23, 2017 Elron Announces Completion of Cloudyn Sale to Microsoft
-
June 29, 2017 Elron Announces Definitive Agreement Signed for Sale of Cloudyn to Microsoft
-
April 20, 2017 Cloudyn in Initial Discussions Over Possible Transaction
-
September 6, 2016 Elron Updates Information on Dividend Distribution
-
August 29, 2016 Elron Announces $15 Million Dividend Distribution
-
August 29, 2016 Elron Appoints New Independent Director
-
June 6, 2016 Elron Announces Court Approval to Distribute $15 Million Dividend
-
May 18, 2016 Elron Updates on Interim Analysis of BrainsGate’s FDA Trial
-
April 11, 2016 Elron Files for Court Approval to Distribute Dividend
-
March 24, 2016 Elron Announces Update on Pocared’s FDA Trial
-
March 13, 2016 Elron Announces Resolution to Make an Application to the Court for a Dividend Distribution of $15 Million
-
March 13, 2016 Elron Announces Decision to Grant Directors’ Compensation to Controlling Persons
-
March 13, 2016 Elron Announces Changes to Board of Directors
-
February 26, 2016 Elron Announces Update on Pocared’s FDA Trial
-
February 15, 2016 Elron Announces Changes to Board of Directors
-
December 22, 2015 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
November 1, 2015 Elron Announces Completion of Acquisition of Jordan Valley
-
October 25, 2015 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
October 6, 2015 Elron Announces Agreement for the Acquisition of Jordan Valley by Bruker
-
September 16, 2015 Elron Announces Signing of Agreement and Completion of Sale of Kyma
-
June 8, 2015 Elron Announces Receipt of Non-Binding Letter of Intent to Acquire Kyma
-
April 15, 2015 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
January 25, 2015 Elron Announces $26 Million Investment Round in BrainsGate
-
December 18, 2014 Elron Electronic Industries to Present at 17th Annual Needham Growth Conference on Tuesday, January 13, 2015
-
November 11, 2014 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
August 24, 2014 Elron Announces $110 Million Dividend Distribution
-
May 19, 2014 Elron Announces BrainsGate Increases FDA Trial Sample Size
-
May 12, 2014 Elron Announces Change of Control over the Company
-
April 7, 2014 Elron Updates on Interim Analysis of BrainsGate’s FDA Trial
-
February 27, 2014 Elron Announces Completion of Acquisition of Given Imaging by Covidien
-
February 3, 2014 Elron Announces that Given Imaging Received FDA Clearance for the PillCam Colon
-
January 27, 2014 Elron Announces that Given Imaging’s SGM Approved its Acquisition by Covidien
-
January 9, 2014 Elron Announces Resignation of Rona Dankner as Director
-
January 6, 2014 Elron Announces Court Rulings in connection with IDB Creditor Arrangement
-
December 18, 2013 Elron Announces IDB Creditor Arrangement
-
December 17, 2013 Elron Announces New Legislation for Increasing Competitiveness and Reducing Market Concentration
-
December 9, 2013 Elron Announces Agreement for the Acquisition of Given Imaging by Covidien
-
December 3, 2013 Elron Extends D&O Liability Insurance Policy under Israeli Company Relief Regulations
-
November 21, 2013 Elron Announces Resignation of Dori Manor as Director
-
November 12, 2013 Elron Announces that Given Imaging Received Reimbursement Approval for the PillCam Colon 2 in Japan
-
November 12, 2013 Elron Announces that BrainsGate Updates Estimate for FDA Trial Completion
-
September 23, 2013 Elron Announces that Given Imaging Received PillCam SB 3 Clearance in Japan
-
September 11, 2013 Elron Announces Completion of Settlement Agreement with Enablence
-
September 3, 2013 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
August 30, 2013 Elron Announces Settlement Agreement with Enablence
-
August 13, 2013 Elron Announces that Given Imaging Received PillCam SB 3 Clearance in the U.S.
-
July 15, 2013 Elron Announces that Given Imaging Received PillCam Colon Clearance in Japan
-
May 9, 2013 Elron Announces Resignation of Gadi Veinrib as Vice President
-
April 25, 2013 Elron Extends Credit Line from Silicon Valley Bank
-
January 15, 2013 Elron Updates that Given Imaging Ends Strategic Options Evaluation, DIC Intends to Consider Sale of Controlling Block of Given Imaging
-
November 27, 2012 Elron Announces Completion of Sync-Rx Sale
-
November 27, 2012 Elron Announces that Given Imaging Submitted PillCam Colon2 Application to FDA for U.S. Regulatory Clearance
-
November 23, 2012 Elron Announces Definitive Agreement Signed for Sale of Sync-Rx
-
October 22, 2012 Elron Issues Reply to Media Reports on Given Imaging
-
October 18, 2012 Elron Announces that Given Imaging is Evaluating Strategic Options
-
September 19, 2012 Elron Announces Non-Binding Term Sheet Signed for Sale of Sync-Rx
-
September 19, 2012 Elron Announces that Given Imaging Filed for Market Approval of PillCam Colon2 in Japan
-
August 21, 2012 Elron Announces Jordan Valley Sale Negotiations Have Ceased
-
August 8, 2012 Elron Announces Given Imaging PillCam Colon2 Clinical Trial Updates
-
August 3, 2012 Elron Announces that Pocared Updates Estimate for FDA Trial Completion
-
July 26, 2012 Elron Announces that BrainsGate Received FDA Approval of Clinical Trial Protocol
-
July 6, 2012 Elron Announces Resignation of Shay Livnat as Director
-
June 26, 2012 Elron Announces $15 Million Dividend Distribution
-
June 26, 2012 Elron Extends D&O Liability Insurance Policy under Israeli Company Relief Regulations
-
May 30, 2012 Elron Issues Reply to Media Reports on Jordan Valley
-
May 29, 2012 Elron Announces that Court Approves Elscint Claim as Class Action
-
May 29, 2012 Elron Receives Additional Consideration and Escrow Deposit for Medingo Sale
-
May 10, 2012 Elron Announces Execution of Agreement to Receive Additional Consideration for Medingo Sale
-
May 9, 2012 Elron Announces that Conditions Precedent for Starling Merger have been Met
-
April 25, 2012 Elron Draws Down $5 Million Loan from Silicon Valley Bank Credit Facility
-
April 2, 2012 Elron Announces that Almost All Conditions Precedent for Starling Merger have been Met
-
February 22, 2012 Elron Expects to Receive $1.3 Million Contingent Consideration for Sale of Wavion
-
February 16, 2012 Elron Announces Results of Negotiations with Starling regarding Merger Transaction
-
January 31, 2012 Elron Proposes to Conduct Negotiations with Starling regarding Merger Transaction
-
January 3, 2012 Elron Announces that Pocared Received CE Certification
-
December 27, 2011 Elron Announces Appointment of Vice President
-
December 27, 2011 Elron Announces Decision to Grant Directors’ Compensation to Controlling Persons
-
December 27, 2011 Elron Early Adopts IFRS 9
-
November 23, 2011 Elron Announces Completion of Wavion Sale
-
November 9, 2011 Elron Receives Credit Facility from Silicon Valley Bank
-
November 9, 2011 Elron Appoints New Director
-
November 9, 2011 Elron Limits Period of Related Party Transactions
-
November 2, 2011 Elron Announces that Pocared has Commenced FDA Trials
-
November 2, 2011 Elron Announces Execution of Agreement for the Sale of Wavion
-
October 10, 2011 Elron Issues Reply to Media Report on Wavion
-
September 27, 2011 Elron Announces Engagement with Foreign Bank to Receive a Bank Credit Line in the Amount of $30 Million
-
September 12, 2011 Elron Announces Completion of Sale of Starling’s Business
-
August 25, 2011 Elron Announces that Starling Entered into Agreement to Sell its Business
-
August 10, 2011 Elron Updates Policy for Classification of Related Party Transactions as Negligible Transactions
-
March 10, 2011 Elron Announces Fourth Quarter and Full Year 2010 Results; Bonus to Chairman
-
September 2, 2010 Elron Announces that Class Action Settlement Agreement is Given Effect of a Judgment
-
August 30, 2010 Elron Announces that DIC will Bear Payment of CEO’s Bonus for the Year 2009
-
August 23, 2010 Elron Announces Execution of Class Action Settlement Agreement
-
July 27, 2010 Elron Announces Negotiations to Settle Class Action
-
June 23, 2010 Elron Announces Completion of Teledata Sale
-
June 9, 2010 Elron Announces that its Audit Committee has Approved Prepayment of Bank Loans and Loans from DIC
-
June 7, 2010 Elron Announces Resignation of Zvi Slovin as Co-Chief Executive Officer
-
May 31, 2010 Elron Announces Completion of the Medingo Sale
-
May 25, 2010 Elron Announces it is Preparing for Completion of Medingo Sale
-
May 23, 2010 Elron Announces Receipt of Regulatory Approvals for Medingo Sale
-
April 19, 2010 Elron Announces Completion of the Sale of Galil Medical
-
April 15, 2010 Elron Announces Execution of Agreement for the Sale of Teledata
-
April 13, 2010 Elron Announces Execution of Agreement for the Sale of Medingo
-
April 1, 2010 Elron Announces Negotiations for the Sale of Medingo
-
March 18, 2010 Elron Announces Fourth Quarter and Full Year 2009 Results; Bonuses for the Year 2009
-
March 15, 2010 Elron Announces Sale of Galil Medical
-
February 11, 2010 Elron Announces Negotiations for the Sale of Teledata
-
January 14, 2010 Elron Announces Policies for Determining Negligibility of Related Party Transactions and Materiality for Immediate Report Requirement
-
January 7, 2010 Elron Announces Shares Delisted from Nasdaq
-
November 12, 2009 Elron Electronic Industries Announces Third Quarter 2009 Results
-
November 12, 2009 Elron Elects to Voluntarily Delist from NASDAQ
-
October 29, 2009 Elron Announces Completion of Sale of Its Holdings in Netvision
-
October 26, 2009 Elron Announces Receipt of Non-Binding Indication of Interest to Acquire Medingo
-
October 22, 2009 Elron Announces Update in Connection with the Sale of its Holding in Netvision
-
October 20, 2009 Elron Announces Update in Connection with Special General Meeting to be Held on October 29, 2009
-
September 30, 2009 Elron Files Proxy Statement in Connection with Special General Meeting on October 29, 2009
-
September 23, 2009 Elron Announces Changes Regarding Annual General Meeting on September 24, 2009 due to Announcement by NetVision
-
August 26, 2009 Elron Files Proxy Statement in Connection with Annual General Meeting on September 24, 2009
-
August 19, 2009 Elron Electronic Industries Announces Second Quarter 2009 Results and Signing of a Definitive Agreement for the Sale of Its Holding in Netvision
-
August 19, 2009 Elron Announces Annual General Meeting of Shareholders on September 24, 2009
-
August 16, 2009 Elron Announces Agreement in Principle on Purchase Price for Sale of its Holding in Netvision
-
July 29, 2009 Elron Group Company Medingo Receives Formal FDA Clearance to Market Its Insulin Micropump in the United States
-
July 28, 2009 Elron Group Company Medingo Receives Informal Clearance Notice from FDA to Market Its Insulin MicroPump in the United States
-
July 5, 2009 Elron Announces Forthcoming Negotiations between IDB’s Group Companies and Elron to Acquire Elron’s Holdings in Netvision Ltd.
-
June 16, 2009 Elron Announces $7 Million Loan Agreement with Discount Investment Corporation
-
June 2, 2009 Elron Group Company 3DV Completes Asset Sale
-
May 20, 2009 Elron Announces IDB’s Group Companies Examining Possibility of Offering to Acquire Elron’s Holdings in Netvision Ltd.
-
May 14, 2009 Elron Electronic Industries Announces First Quarter 2009 Results
-
March 30, 2009 Elron Announces Appeal against Dismissal of Purported Class Action Filed in 1999
-
March 29, 2009 Elron Group Company 3DV Signs Definitive Asset Sale Agreement
-
March 24, 2009 Elron Files Proxy Statement in Connection with Special General Meeting on April 22, 2009
-
March 18, 2009 Elron Announces Special Meeting of Shareholders on April 22, 2009
-
March 11, 2009 Elron Electronic Industries Announces Fourth Quarter and Full Year 2008 Results
-
March 5, 2009 Elron Schedules Fourth Quarter 2008 Results Release for Thursday, March 12, 2009
-
February 16, 2009 Elron Group Company, Teledata, Wins $16.2M Project from ICE Costa Rica
-
February 4, 2009 Elron Issues Proxy in Connection with Special General Meeting on March 3, 2009
-
January 25, 2009 Elron Announces Special Meeting of Shareholders on March 3, 2009
-
January 25, 2009 Elron Announces Dismissal of a Purported Class Action Filed in 1999
-
January 15, 2009 Elron Announces Loan Agreement with Discount Investment Corporation
-
November 25, 2008 Elron Announces Discount Investment Corporation Considering Possibilities for Going Private Transaction Involving Elron
-
November 23, 2008 Elron Highlights Developments in Group Companies: Starling, Wavion & Safend
-
November 23, 2008 Elron Issues Proxy in Connection with Annual General Meeting on December 24, 2008
-
November 16, 2008 Elron Announces Annual General Meeting of Shareholders on December 24, 2008
-
November 13, 2008 Elron Electronic Industries Announces Third Quarter 2008 Results
-
November 11, 2008 Elron Group Company Galil Medical Signs Definitive Merger Agreement with Endocare, Inc. (NASDAQ:ENDO); Merged Company Signs $16 Million Financing Agreements with Existing Investors
-
November 6, 2008 Elron Schedules Third Quarter 2008 Results Release for Thursday, November 13, 2008
-
November 5, 2008 Elron Group Companies Chosen among Israel’s Fastest Growing Companies for 2008 by Deloitte Fast 50
-
November 2, 2008 Elron Announces that Netvision Cancelled Agreement to Acquire Shares in Hot Communications
-
October 30, 2008 Elron Announces Loan Agreement With Discount Investment Corporation
-
October 28, 2008 Elron Completes Partial Tender Offer For Cash For Starling Convertible Debentures
-
October 12, 2008 Elron Commences Partial Tender Offer For Cash For Starling Advanced Communications Convertible Debentures
-
October 7, 2008 Elron Announces Appointment Of New Director
-
October 5, 2008 Elron Announces Purchases of Starling Convertible Debentures
-
October 5, 2008 Elron Announces that NetVision Received Notification from Israel Antitrust Authority Regarding Agreement to Acquire Shares in HOT
-
October 2, 2008 Elron Announces that NetVision has not Timely Received All Required Approvals to Acquire Shares in HOT
-
September 28, 2008 Elron Announces Support by Principal Shareholders for Starling
-
September 24, 2008 Technology of Elron’s Company, Starling, to be Incorporated in Antennas at Estimated Value for Starling of $60M
-
September 17, 2008 Elron’s CEO to Present at the NASDAQ-TASE Israel Investor Conference in New York
-
September 17, 2008 Elron Highlights Developments in Teledata and Ellara group companies
-
September 10, 2008 Elron Issues Proxy in Connection with Special General Meeting on October 12, 2008
-
September 3, 2008 Elron Announces Special General Meeting of Shareholders on October 12, 2008
-
August 14, 2008 Elron Electronic Industries Announces Second Quarter 2008 Results
-
August 7, 2008 Elron Second Quarter 2008 Results Release Scheduled for Thursday, August 14, 2008
-
July 24, 2008 Elron Highlights Development in Group Company Starling
-
July 10, 2008 Elron Highlights Developments in Group Companies – Atlantium & Wavion
-
July 3, 2008 Elron Files Annual Report for 2007 on Form 20-F
-
July 2, 2008 Elron’s CEO to Present at the Collins Stewart Growth Conference in New York
-
June 22, 2008 Elron Completes Partial Tender Offer for Given Imaging
-
June 16, 2008 Elron Commences Additional Offer Period for Given Imaging Tender Offer
-
May 18, 2008 Elron Electronic Industries Announces First Quarter 2008 Results
-
May 16, 2008 Elron Commences Partial Tender Offer for Cash for Given Imaging
-
May 13, 2008 Elron’s First Quarter Earnings Conference Call Scheduled for Monday, May 19th, 2008
-
May 13, 2008 Elron’s First Quarter Earnings Conference Call Scheduled for Monday May 19th2008
-
May 5, 2008 Elron Announces that NetVision has Signed an Agreement to Acquire Shares in HOT
-
April 22, 2008 Elron Announces Key Developments and Market Recognition in Certain Group Companies
-
April 21, 2008 Elron Announces that NetVision has Submitted an Offer to Acquire Shares in Hot
-
April 21, 2008 Elron Announces that Given Imaging Announces Patent Litigation Settlement
-
April 17, 2008 Elron Announces that NetVision is in Negotiations to Acquire Shares in Hot
-
March 25, 2008 Elron Highlights AqWise and Galil Medical Developments
-
March 13, 2008 Elron Announces Fourth Quarter and Full Year 2007 Results
-
March 6, 2008 Elron Issues Proxy in Connection with Special Shareholders Meeting on April 2, 2008
-
March 6, 2008 Elron to Host Fourth Quarter and Full Year 2007 Earnings Conference Call on Thursday, March 13, 2008
-
February 25, 2008 Elron Announces Special General Meeting of Shareholders on April 2, 2008
-
February 19, 2008 Elron Group Company, Safend, Closes Funding Round; Named Winner of Info Security Products Guide 2008 Global Excellence Award
-
January 19, 2008 Elron Announces that Given Imaging Receives NSE Letter from the FDA Regarding its Application to Market Pillcam® Colon
-
January 14, 2008 Elron Announces that Dr. Zvika Slovin Joining Team as VP Medical Devices and Life Science
-
December 30, 2007 Elron Announces Agreement with Rafael and Settlement of Claim by Rafael Against Elron’s Subsidiaries, DEP and RDC
-
November 20, 2007 Elron Announces Third Quarter 2007 Results
-
November 20, 2007 Elron Group Company, Medingo, Announces $27 Million Financing; Elron will Invest up to $22 Million
-
November 13, 2007 Elron to Host Third Quarter Earnings Conference Call on Tuesday, November 20, 2007
-
October 16, 2007 Elron Announces $11 Million Investment by Intel Capital in Elron Group Company, Jordan Valley
-
September 20, 2007 Elron Issues Proxy in Connection with Annual General Meeting on October 18, 2007
-
September 11, 2007 Elron Announces Annual General Meeting of Shareholders on October 18, 2007
-
August 16, 2007 Elron Electronic Industries Announces Net Income of $3.4 Million in the First Half of 2007
-
August 9, 2007 Elron to Host Second Quarter Earnings Conference Call on Thursday, August 16, 2007
-
July 11, 2007 Elron Completes Second Investment in the Field of Internet and Cellular Through $1 Million Investment in MuseStorm
-
July 1, 2007 Elron Enters the Field of Internet and Cellular Through an Initial Investment in Journeys, a Massive Multiplayer On-Line Gaming Venture
-
June 18, 2007 Elron Announces Completion of Sale of Carmiel Real Estate for Approximately $11.6 Million
-
June 13, 2007 Elron Announces That Starling Has Completed Its Initial Public Offering On The Tel Aviv Stock Exchange
-
June 12, 2007 Elron Announces New Investment in Pocared
-
May 30, 2007 Elron Announces New Investment in RadLive
-
May 30, 2007 Elron Updates on Developments of Proposed IPO Processes of Three of its Group Companies
-
May 27, 2007 Elron Completes Purchase of 2.5% of Ordinary Shares of Given Imaging
-
May 21, 2007 Elron Electronic Industries Reports $2.6 Million Net Income in the First Quarter of 2007
-
May 16, 2007 Elron to Hold First Quarter Earnings Conference Call on Monday, May 21, 2007
-
May 16, 2007 Discount Investment Files Preliminary Statement Prior to Possible Tender Offer
-
May 15, 2007 Elron Announces Purchase of Approximately 340,000 Shares of Given Imaging for Approximately $8.6 Million
-
May 10, 2007 Elron to Host First Quarter Earnings Conference Call on Thursday, May 17, 2007
-
May 2, 2007 Elron Announces Agreement to Sell Carmiel Real Estate for Approximately $11.6 Million
-
April 29, 2007 Elron Announces Filing by Three of its Group Companies of Requests to Register Shares for Trading on the TASE
-
April 19, 2007 Elron Announces New Investment in BPT
-
April 18, 2007 Elron Issues Audited Financial Results for 2006
-
April 17, 2007 Elron Announces Special General Meeting of Shareholders to be Held on May 28, 2007
-
March 15, 2007 Elron Announces Completion of Acquisition of 34% Interest in AqWise
-
March 14, 2007 Elron Announces Fourth Quarter and Year End 2006 Results
-
March 11, 2007 Elron to Host Fourth Quarter and Year End 2006 Earnings Conference Call on Wednesday, March 14, 2007
-
February 21, 2007 Elron Announces Acquisition by ChipX of Oki’s U.S. ASIC Business Assets
-
January 25, 2007 Elron Announces Completion of NetVision-Barak-GlobeCall Merger
-
January 24, 2007 Elron’s Companies – Given Imaging and Brainsgate Receive The WEF’s Technology Pioneer Award
-
January 22, 2007 Elron Announces Extension to Complete NetVision-Barak-GlobeCall Merger Until January
-
January 18, 2007 Elron Approved By Nasdaq for Inclusion in Nasdaq Global Select Market
-
January 8, 2007 Elron Announces Appointment of New Chairman
-
January 4, 2007 Elron Announces Ministry of Communications Approval for NetVision-Barak-GlobeCall Merger
-
December 31, 2006 Elron Announces Completion of Sale of All Its Partner Shares for Approximately $40 Million
-
December 27, 2006 Elron Announces Shareholder Approvals for NetVision-Barak-GlobeCall Merger
-
December 21, 2006 Elron Eliminates an Agenda Item From Its Annual General Meeting on December 28, 2006
-
December 12, 2006 3DV Systems, an Elron Group Company, Completes $15 Million Investment Round
-
December 10, 2006 Elron Announces Completion By Galil Medical of $52 Million Financing and Acquisition of Oncura’s Urology Related Cryotherapy Business
-
December 7, 2006 Elron Reaches Agreement to Sell Approximately 3.9 Million Partner Shares For Approximately $40 Million
-
December 4, 2006 Elron Announces Likely Range of Accounting Impact of Galil-Oncura Transaction on Elron’s Financial Results
-
November 30, 2006 Elron Announces Results of Discount Investment Cash Tender Offer for Certain of Elron’s Shares
-
November 30, 2006 Elron Issues Proxy in Connection with Annual General Meeting on December 28, 2006
-
November 27, 2006 Galil Medical, an Elron Group Company, Signs Definitive Agreements to Sell Interest in Oncura and to Acquire Oncura’s Urology Related Cryotherapy Business
-
November 22, 2006 Galil Medical, an Elron Group Company, Announces Term Sheet for New Financing of $40 Million
-
November 22, 2006 Galil Medical, an Elron Group Company, in Advanced Negotiations to Sell Its Interest In Oncura and to Acquire Oncura’s Urology Related Cryotherapy Business
-
November 21, 2006 3DV Systems, an Elron Group Company, Signs Definitive Agreement in Connection with $15 Million Investment Round
-
November 21, 2006 Elron Announces Annual General Meeting of Shareholders on December 28, 2006
-
November 14, 2006 Elron Electronic Industries Announces Third Quarter 2006 Results
-
November 8, 2006 Elron to Report Third Quarter Financial Results on November 14
-
October 31, 2006 Elron Files Schedule 14D-9 in response to Discount Investment Cash Tender Offer for Certain Elron Shares
-
October 25, 2006 Elron Announces Commencement by Discount Investment Corporation of Cash Tender Offer for Certain Elron Shares
-
October 25, 2006 Antitrust Authority Approval for the NetVision-Barak-GlobeCall Merger
-
October 24, 2006 Elron Announces New Investment in Atlantium
-
September 20, 2006 Rafael Files Claim Against Elron’s Subsidiaries, DEP and RDC
-
September 7, 2006 Netvision Signs Definitive Agreements to Merge with Barak and GlobeCall
-
August 28, 2006 Discount Investment Files Preliminary Statement Prior to Possible Tender Offer
-
August 27, 2006 Elron Announces New Investment in Neurosonix
-
August 14, 2006 Elron Electronic Industries Announces Second Quarter 2006 Results
-
August 9, 2006 Elron Announces Purchase of Approximately 540,000 Shares of Given Imaging for Approximately $10 Million
-
August 6, 2006 Elron to Report Second Quarter Financial Results on August 13, 2006
-
July 30, 2006 Elron Announces Progress in the Merger Discussions Between Netvision and Barak
-
June 11, 2006 Elron Announces Completion of $14 Million Financing in AMT
-
May 16, 2006 Elron Electronic Industries Reports First Quarter 2006 Results
-
May 9, 2006 Elron to Report First Quarter Financial Results on May 16, 2006
-
May 1, 2006 Elron Announces Netvision to Commence Merger Discussions with Barak
-
March 15, 2006 Elron Electronic Industries Announces: $47.3 Million Net Income in 2005; $47 Million Investment in 2005; And $134 Million Cash Balance at Year-End
-
March 8, 2006 Elron Signs Definitive Agreement to Acquire Approx. 823,000 Partner Shares From Polar Communications for Approximately $5.3 Million
-
March 8, 2006 Elron to Report Fourth Quarter and Full Year 2005 Financial Results on March 15, 2006
-
February 13, 2006 Elron Announces Special General Meeting of Shareholders
-
January 4, 2006 Elron Announces New Investment of $3.7 Million in Safend
-
December 21, 2005 Elron Announces Sale of Elron Telesoft to ECtel
-
November 8, 2005 Elron Announces Net Income of $4.8 Million in the Third Quarter of 2005 and $46.8 Million in the Nine Month Period Ended September 30, 2005
-
November 1, 2005 Elron to Report Third Quarter 2005 Financial Results on November 8, 2005
-
October 10, 2005 Elron Announces That Tal Raz, Elrons CFO, Will Be Leaving Elron to Join Cellcom as CFO
-
October 2, 2005 Elron Announces New Investment of $4 Million in Gaia
-
September 13, 2005 Elron Announces That NASDAQ’s Ex Dividend Date is September 16, 2005
-
September 5, 2005 Elron Declares Cash Dividend of $3.00 Per Share Totaling Approximately $89 Million
-
August 11, 2005 Elron Announces New Investment of Approximately $7 Million in Brainsgate
-
August 10, 2005 Elron Electronic Industries Announces Net Income of $47.2 Million in the Second Quarter of 2005
-
August 3, 2005 Elron to Report Second Quarter 2005 Financial Results on August 10, 2005
-
June 12, 2005 Elron Announces Completion of Zoran’s Acquisition of Elron’s 41% Held Affiliate, Oren Semiconductors
-
May 19, 2005 Elron Announces That Netvision Has Completed Its Initial Public Offering on the Tel Aviv Stock Exchange
-
May 17, 2005 Elron Electronic Industries Reports First Quarter 2005 Results
-
May 15, 2005 Elron Announces That Netvision Has Published a Prospectus For an Initial Public Offering on the Tel Aviv Stock Exchange
-
May 10, 2005 Elron to Report First Quarter 2005 Financial Results on May 17, 2005
-
May 9, 2005 Elron Announces New Investment of $16 Million in Teledata Networks Ltd.
-
May 9, 2005 Elron Announces Signing of Agreement by Elron’s 41% Held Affiliate, Oren Semiconductors, For Its Acquisition by Zoran for $53.5 Million
-
May 8, 2005 Elron Announces Annual General Meeting of Shareholders on June 7, 2005
-
April 21, 2005 Elron Announces New Investment of $2.9 Million in Nulens
-
April 20, 2005 Elron Announces Completion of Sale of Approx. 12.8 Million Partner Shares to Partner for Approx. $94 Million
-
March 10, 2005 Elron Announces Special General Meeting of Shareholders on April 21, 2005
-
March 2, 2005 Elron Electronic Industries Announces Record Results of $ 84.1 Million Net Income in 2004
-
February 24, 2005 Elron to Report Fourth Quarter and Year End 2004 Financial Results on March 2, 2005
-
February 24, 2005 Elron Announces Approval by Partner’s Board of Directors of Acceptance of Elron’s Offer Together With Eurocom and Polar to Sell Partner Shares to Partner
-
February 8, 2005 Elron Announces Offer Together With Eurocom and Polar to Sell Approx. 31.7 Million Partner Shares to Partner
-
December 29, 2004 Elron Announces New Investment of Approximately $7.3 Million in Impliant
-
November 10, 2004 Elron Announces Net Income of $70.8 Million in the Third Quarter of 2004 and $80.0 Million in the Nine Month Period Ended September 30, 2004
-
November 8, 2004 Elron Announces Purchase of 323,513 Additional Shares of Given Imaging Ltd. for Approximately $9.9 Million
-
November 4, 2004 Elron Announces Purchase of 500,000 Additional Shares of Given Imaging Ltd. for Approximately $14.8 Million
-
November 4, 2004 Elron to Report Third Quarter 2004 Financial Results on November 10, 2004
-
October 21, 2004 Elron Announces Completion of Investment of Approx. $6.7 Million in Jordan Valley Applied Radiation Ltd
-
September 26, 2004 Elron Announces Special General Meeting of Shareholders on October 21, 2004
-
August 22, 2004 Elron Announces Completion of Discount Investment Cash Tender Offer For Certain of Elron’s Shares
-
August 11, 2004 Elron Electronic Industries Announces Net Income of $5.5 Million and $9.2 Million in the Second Quarter and First Half of 2004
-
August 10, 2004 Elron Announces Investment of Approximately $6.7 Million in Jordan Valley Applied Radiation Ltd.
-
August 5, 2004 Elron Announces Purchase of 463,000 Shares of Given Imaging Ltd. for Approximately $16.2 Million
-
July 28, 2004 Elron Announces Completion of the Sale of All Its Holdings in Elbit Systems to Federmann Enterprises Ltd. for approximately $197 million
-
July 28, 2004 Elron Responds to Discount Investment Cash Tender Offer for Certain Elron Shares
-
July 16, 2004 Elron Announces Commencement by Discount Investment Corporation of Cash Tender Offer for Certain Elron Shares
-
July 8, 2004 Elron Announces Signing of Definitive Agreement to Sell All of Its Holdings in Elbit Systems For Approx. $197 Million
-
June 30, 2004 Elron Announces Completion of $6 Million Investment in AMT By Elron and Strategic Partner
-
June 18, 2004 Elron Announces That Given Imaging Has Completed Pricing of Its Secondary Public Offering
-
May 12, 2004 Elron Electronic Industries Announces Net Income of $3.7 Million in the First Quarter of 2004
-
April 28, 2004 Elron’s Annual General Meeting of Shareholders Will Be Held on May 30, 2004
-
April 1, 2004 Elron Electronic Industries Announces Sale of Kit eLearning to Sylvan Learning Systems
-
March 31, 2004 Elron Announces Filing by Netvision of Request to Register Its Shares for Trading on the Tel Aviv Stock Exchange
-
March 10, 2004 Elron Electronic Industries Reports Fourth Quarter and Year End Results for 2003
-
January 28, 2004 Elron Announces Special General Meeting of Shareholders on February 29, 2004
-
November 23, 2003 Elron Announces Sale of Approximately 850,000 Shares of Zix Corporation
-
November 12, 2003 Elron Electronic Industries Announces Net Income of $3.0 Million in the Third Quarter of 2003
-
October 27, 2003 Elrons Annual General Meeting of Shareholders Will Be Held on November 30, 2003
-
September 2, 2003 Elron Electronic Industries Announces Sale of Elron Software’s Assets and Business to Zix Corporation
-
August 13, 2003 Elron Electronic Industries Announces Significant Decrease in Net Loss In the Second Quarter and First Half of 2003
-
August 12, 2003 Elron Announces Sale of Approximately 2.8 Million Shares of Partner Communications Company Ltd.
-
August 3, 2003 Oren Semi-Conductor, an Elon Group Company, Completes $8.0 Million Private Placement
-
July 2, 2003 Galil Medical, an Elron Subsidiary, and Amersham Complete Merger of Urology Therapy and Brachytherapy Units
-
June 1, 2003 Wavion, an Elron Group Company, Completes $6 Million Private Placement
-
May 29, 2003 Elron Announces Sale of 2.1 Million Shares of Partner Communications Company Ltd.
-
May 29, 2003 Elron Announces Sale of Additional 1 Million Shares of Partner Communications Company Ltd.
-
May 21, 2003 Elron Electronic Industries Reports First Quarter 2003 Results
-
March 12, 2003 Elron Electronic Industries Reports Fourth Quarter and Year End Results for 2002
-
February 2, 2003 Elron Announces Special General Meeting of Shareholders
-
January 27, 2003 Elron Announces New $2 Million Investment in Notal Vision
-
November 26, 2002 Elron Announces Sale of 380,000 Shares of Elbit Systems Ltd
-
November 12, 2002 Elron Electronic Industries Third Quarter Results
-
September 19, 2002 Elron Announces Acquisition of Certain Assets of Elbit Vflash by 24/7 Real Media and an Investment into 24/7 Real Media
-
August 7, 2002 Elron Electronic Industries Second Quarter Results
-
August 6, 2002 Elron Announces Completion of New Investment of $5 Million in A.M.T. Advanced Metal Technologies Ltd.
-
June 2, 2002 Elron’s Annual General Meeting of Shareholders will be Held on July 3, 2002
-
May 16, 2002 Elron Announces Completion of Merger With Elbit
-
May 14, 2002 Elron Electronic Industries Announces First Quarter Results
-
May 9, 2002 Elron Announces that Court Grants Final Approval of Merger With Elbit
-
May 6, 2002 Elron Announces Completion of Share Purchase Agreement with Discount Investment Corporation Ltd.
-
April 28, 2002 Elron Announces that Elron Shareholders Approve Merger with Elbit
-
March 27, 2002 Elron Announces That the Form F-4 Registration Statement and the Israeli Prospectus Relating to its Proposed Merger with Elbit has been Declared Effective by the Securities and Exchange Commission and the Israeli Securities Authority
-
March 25, 2002 Elron Electronic Industries 2001 Year End and Fourth Quarter Results
-
March 6, 2002 Elron Announces That Given Imaging Has Announced the Withdrawal of Its Registration Statement In Connection with Proposed Public Offering
-
February 26, 2002 Elron Electronic Industries Expects to Record Increased Losses In the Fourth Quarter of 2001
-
February 14, 2002 Elron Clarifies Press Release of January 29, 2002 Regarding Registration Statement Filed by Given Imaging
-
January 29, 2002 Elron Announces that Given Imaging Held Directly and Indirectly 11.5% by Elron Files Registration Statement For Proposed Public Offering of Ordinary Shares